Skip to main content
Livermore
Livermore
ZHEN

Payden & Rygel

SEC CIK
0000919219
Latest filing
Jul 31, 2026

PFE holding history

Pfizer Inc in every 13F filed by Payden & Rygel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PFE overviewAll 13F holders of PFEFull Q2 2026 holdings

Shares (Q2 2026)
311,580
Value
$7.50M
% of portfolio
0.6%
Quarters held
22
Since Q1 2021
Holdings of PFE by Payden & Rygel, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026311,580$7.50M0.6%+2,000+0.6%AddedHolders
Q1 2026309,580$8.69M0.7%+104,500+51.0%AddedHolders
Q4 2025205,080$5.11M0.4%+204,700+53,868.4%AddedHolders
Q3 2025380$10.0K<0.1%−24,300−98.5%ReducedHolders
Q2 202524,680$598.0K<0.1%00.0%UnchangedHolders
Q1 202524,680$625.0K0.1%00.0%UnchangedHolders
Q4 202424,680$655.0K0.1%−289,300−92.1%ReducedHolders
Q3 2024313,980$9.09M0.7%+284,000+947.3%AddedHolders
Q2 202429,980$839.0K0.1%−240,400−88.9%ReducedHolders
Q1 2024270,380$7.50M0.5%+240,400+801.9%AddedHolders
Q4 202329,980$863.0K0.1%00.0%UnchangedHolders
Q3 202329,980$994.0K0.1%+24,300+427.8%AddedHolders
Q2 20235,680$208.0K<0.1%−244,590−97.7%ReducedHolders
Q1 2023250,270$10.2M0.6%−243,720−49.3%ReducedHolders
Q4 2022493,990$25.3M1.3%−359,500−42.1%ReducedHolders
Q3 2022853,490$37.3M2.2%+20,800+2.5%AddedHolders
Q2 2022832,690$43.7M2.6%+126,700+17.9%AddedHolders
Q1 2022705,990$36.5M1.8%+209,520+42.2%AddedHolders
Q4 2021496,470$29.3M1.4%00.0%UnchangedHolders
Q3 2021496,470$21.4M1.1%00.0%UnchangedHolders
Q2 2021496,470$19.4M0.9%−3,100−0.6%ReducedHolders
Q1 2021499,570$18.1M0.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.